Zydus Lifesciences Secures Majority Control of Amplitude Surgical, Set to Exceed 90% Ownership After Tender Offer

Zydus Lifesciences has made a definitive move towards its MedTech international growth with the execution of undertakings from seven influential shareholders to offer combined 2.2 million shares of France-headquartered Amplitude Surgical. The move comes as part of an overarching agreement for over 90% of equity of Amplitude Surgical after having sealed a first tranche agreement for acquisition of 85.6% at €6.25 a share—a more than 80% premium on the last close.

 

Key Highlights

Source: Zydus Lifesciences, Economic Times, Business Standard, Moneycontrol